MicroRNA signature in skeletal muscle in type 2 Diabetes [human]
收藏官方服务：
资源简介：
MicroRNA signature in skeletal muscle in type 2 Diabetes [human]
应用场景：
创建时间：
2015-04-25
相关数据集
File S1 - Increased Plasma DPP4 Activity Is an Independent Predictor of the Onset of Metabolic Syndrome in Chinese over 4 Years: Result from the China National Diabetes and Metabolic Disorders Study
Table S1. ORs for new-onset metabolic syndrome components according to baseline DPP4 activity (nmol/ml/min); Table S2. ORs for new-onset metabolic syndrome components according to baseline active GLP-
Figshare2015-12-02 更新70
Comprehensive Quantification of Carboxymethyllysine-Modified Peptides in Human Plasma
A prolonged hyperglycemic condition in diabetes mellitus results in glycation of plasma proteins. N(ε)-Carboxymethyllysine (CML) is a well-known protein advanced glycation end product, and one of its
NIAID Data Ecosystem60
Comprehensive Identification of Glycated Peptides and Their Glycation Motifs in Plasma and Erythrocytes of Control and Diabetic Subjects
Nonenzymatic glycation of proteins sets the stage for formation of advanced glycation end-products and development of chronic complications of diabetes. In this report, we extended our previous method
Figshare2016-02-23 更新40
Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction
Beta cell dysfunction accompanies and drives the progression of type 2 diabetes mellitus (T2D), but there are few clinical biomarkers available to assess islet cell stress in humans. Secretagogin, a p
NIAID Data Ecosystem60
Tryptophan/Kynurenine pathway metabolite concentrations in T1D patients.
Tryptophan/Kynurenine pathway metabolite concentrations in T1D patients.
NIAID Data Ecosystem50
